A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice

Journal of Virology

Volumn 74, Issue 9, 2000, Pages 4047-4056

  Chapman, Nora M ^a,d   Ragland, Anna ^a,b   Leser, J Smith ^a   Höfling, Katja ^a   Willian, Sandra ^a   Semler, Bert L ^c   Tracy, Steven ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; COXSACKIE VIRUS VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; DRUG EFFICACY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREATITIS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; VACCINATION; VACCINE PRODUCTION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN;

5' UNTRANSLATED REGIONS; ANIMALS; BLOTTING, WESTERN; CAPSID; CELLS, CULTURED; COS CELLS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; MALE; MICE; MICE, INBRED C3H; POLIOVIRUS; PROTEIN BIOSYNTHESIS; TUMOR CELLS, CULTURED; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0034003423     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.9.4047-4056.2000     Document Type: Article

References (57)

1. Agol, V. 1991. The 5′ untranslated region of picornaviral genomes. Adv. Virus Res. 40:103-180.
2. Andino, R., N. Boddeker, D. Silvera, and A. Gamarnik. 1999. Intracellular determinants of picornavirus replication. Trends Microbiol. 7:76-82.
3. Andino, R., G. E. Rickehof, and D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′ end of the viral RNA. EMBO J. 12:3587-3598.
4. Andino, R., D. Silvera, S. D. Suggett, P. L. Achaso, C. J. Miller, D. Baltimore, and M. Feinberg. 1994. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science 265:1448-1451.
5. Beck, M., and S. Tracy. 1989. Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s). J. Virol. 63:4148-4156.
6. Belsham, G. J., and N. Sonenberg. 1996. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60:499-511.
7. Bienkowska-Szewczyk, K., and E. Ehrenfeld. 1988. An internal 5′-noncoding region required for translation of poliovirus RNA in vitro. J. Virol. 62:3068-3072.
8. Blyn, L. B., K. M. Swiderek, O. Richards, D. C. Stahl, B. L. Semler, and E. Ehrenfeld. 1996. Poly(rC) binding protein 2 hinds to stemloop IV of the poliovirus RNA 5′ noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 93:11115-11120.
9. Blyn, L. B., J. S. Towner, B. L. Semler, and E. Ehrenfeld. 1997. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J. Virol. 71:6243-6246.
10. Chapman, N. M., A. I. Ramsingh, and S. Tracy. 1997 Genetics of coxsackievirus virulence. Curr. Top. Microbiol. Immunol. 223:227-258.
11. Chapman, N. M., Z. Tu, S. Tracy, and C. J. Gauntt. 1994. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135:115-130.
12. Currey, K. M., and B. A. Shapiro. 1997. Secondary structure computer prediction of the poliovirus 5′ non-coding region is improved by a genetic algorithm. Comput. Appl. Biosci. 13:1-12.
13. Dalldorf, G. 1955. The coxsackie viruses. Annu. Rev. Microbiol. 9:277-296.
14. Dalldorf, G., and R. Gifford. 1952. Adaptation of group B coxsackie virus to adult mouse pancreas. J. Exp. Med. 95:491-497.
15. Dowdle, W. R., D. A. Featherstone, M. F. Birmingham, H. F. Hull, and R. Aylward. 1999. Poliomyelitis eradication. Virus Res. 62:185-192.
16. Evans, D., G. Dunn, P. D. Minor, G. C. Schild, A. J. Cann, G. Stanway, J. W. Almond, K. Currey, and J. Maizel. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314:548-550.
17. Francki, R., C. Fauquet, D. Knudson, and F. Brown. 1991. Classification and nomenclature of viruses. Springer-Verlag, Vienna, Austria.
18. Freistadt, M. S., and K. E. Eberle. 1996. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J. Virol. 70:6486-6492.
19. Gamarnik, A. V., and R. Andino. 1997. Two functional complexes formed by KH domain containing proteins with the 5′ noncoding region of poliovirus RNA. RNA 3:882-892.
20. Gauntt, C. J., P. T. Gomez, P. S. Duffey, J. A. Grant, D. W. Trent, S. M. Witherspoon, and R. E. Paque. 1984. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J. Virol. 52:598-605.
21. Godeny, E., H. M. Arizpe, and C. J. Gauntt. 1987. Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3 induced myocarditis. Viral Immunol. 1:305-314.
22. Gomez, R. M., E. F. Lascano, and M. I. Berria. 1991. Murine acinar pancreatitis preceding necrotizing myocarditis after coxsackievirus B3 inoculation. J. Med. Virol. 35:71-75.
23. Gomez, R. M., X. Cui, C. G. Castagnino, and M. I. Berria. 1993. Differential behavior in pancreas and heart of two coxsackievirus B3 variants. Intervirology 36:153-160.
24. Gromeier, M., L. Alexander, and E. Wimmer. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. USA 93:2370-2375.
25. Gutierrez, A. L., M. Denova-Ocampo, V. R. Racaniello, and R. M. del Angel. 1997. Attenuating mutations in the poliovirus 5′ untranslated region alter its interaction with polypyrimidine tract-binding protein. J. Virol. 71:3826-3833.
26. Hyypia, T., T. Hovi, N. Knowles, and G. Stanway. 1997. Classification of enteroviruses based on molecular and biological properties. J. Gen. Virol. 78:1-11.
27. Iizuka, N., H. Yonekawa, and A. Nomoto. 1991. Nucleotide sequences important for translation initiation of enterovirus RNA. J. Virol. 65:4867-4873.
28. Jackson, R. J., and A. Kaminski. 1995. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1:985-1000.
29. Johnson, V. H., and B. L. Semler. 1988. Defined recombinants of poliovirus and coxsackievirus: sequence-specific deletions and functional substitutions in the 5′-noncoding regions of viral RNAs. Virology 162:47-57.
30. Kuge, S., and A. Nomoto. 1987. Construction of viable deletion and insertion mutants of the Sabin strain of type poliovirus: function of the 5′ noncoding sequence in viral replication. J. Virol. 61:1478-1487.
31. Kuhn, R. J., E. Wimmer, and B. L. Semler. 1987. Expression of the poliovirus genome from infectious cDNA is dependent upon arrangements of eukaryotic and prokaryotic sequences in recombinant plasmids. Virology 157:560-564.
32. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
33. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
34. Le, S. Y., and M. Zuker. 1990. Common structures of the 5′ non-coding RNA in enteroviruses and rhinoviruses. J. Mol. Biol. 216:729-741.
35. Lee, C., E. Maull, N. Chapman, S. Tracy, J. Wood, and C. Gauntt. 1997. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs. Virus Res. 50:225-235.
36. Lu, H., and E. Wimmer. 1996. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc. Natl. Acad. Sci. USA 93:1412-1417.
37. Meerovitch, K., Y. V. Svitkin, H. S. Lee, F. Lejbkowicz, D. J. Kenan, E. K. Chan, V. I. Agol, J. D. Keene, and N. Sonenberg. 1993. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67:3798-3807.
38. Modlin, J. F., and H. A. Rotbart. 1997. Group B coxsackievirus disease in children. Curr. Top. Microbiol. Immunol. 223:53-80.
39. Nicholson, R., J. Pelletier, S. Y. Le, and N. Sonenberg. 1991. Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies. J. Virol. 65:5886-5894.
40. Palmenberg, A. C., and J.-Y. Sgro. 1997. Topological organization of picornaviral genomes: statistical prediction of RNA structural signals. Semin. Virol. 8:231-241.
41. Parsley, T. B., J. S. Towner, L. B. Blyn, E. Ehrenfeld, and B. L. Semler. 1997. Poly (rC) binding protein 2 forms a ternary complex with the 5-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 3:1124-1134.
42. Poyry, T., L. Kinnunen, T. Hyypia, B. Brown, C. Horsnell, T. Hovi, and G. Stanway. 1996. Genetic and phylogenetic clustering of enteroviruses. J. Gen. Virol. 77:1699-1717.
43. Ramsingh, A. I., N. M. Chapman, and S. Tracy. 1997. Coxsackieviruses and diabetes. Bioessays 19:793-800.
44. Romero, J. R., C. Price, and J. J. Dunn. 1997. Genetic divergence among group B Coxsackieviruses. Curr. Top. Microbiol. Immunol. 223:97-152.
45. Romero, J. R., and H. A. Rotbart. 1995. Sequence analysis of the downstream 5′ nontranslated region of seven echoviruses with different neurovirulence phenotypes. J. Virol. 69:1370-1375.
46. Schoub, B. D., S. Johnson, J. M. McAnerney, I. L. Dos Santos, and K. I. Klaassen. 1985. Epidemic coxsackie B virus infection in Johannesburg, South Africa. J. Hyg. (London) 95:447-455.
47. Semler, B. L., V. H. Johnson, and S. Tracy. 1986. A molecular recombinant plasmid from cDNA clones of poliovirus and coxsackievirus produces an infectious virus that is temperature sensitive. Proc. Natl. Acad. Sci. USA 83:1777-1781.
48. Semler, B. L., A. Dorner, and E. Wimmer. 1984. Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res. 12:5123-5141.
49. Skinner, M., V. Racaniello, G. Dunn, J. Cooper, P. D. Minor, and J. W. Almond. 1989. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J. Mol. Biol. 207:379-392.
50. Svitkin, Y. V., S. V. Maslova, and V. I. Agol. 1985. The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147:243-252.
51. Tracy, S., N. M. Chapman, and H. L. Liu. 1985. Molecular cloning and partial characterization of the coxsackievirus B3 genome. Arch. Virol. 85: 157-163.
52. Tracy, S., N. M. Chapman, and Z. Tu. 1992. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 122:399-409.
53. Tracy, S., and C. J. Gauntt. 1988. Phenotypic and genotypic differences among naturally occurring coxsackie B3 virus variants. Europ. Heart J. 8(Suppl. J):445-448.
54. Tracy, S., K. Höfling, S. Pirruccello, P. H. Lane, S. M. Reyna, and C. J. Gauntt. Group B coxsackievirus myocarditis and pancreatitis in mice: connection between viral virulence phenotypes. J. Med. Virol., in press.
55. Tu, Z., N. M. Chapman, G. Hufnagel, S. Tracy, J. R. Romero, W. H. Barry, K. Currey, and B. Shapiro. 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J. Virol. 69:4607-4618.
56. Wimmer, E., C. U. Hellen, and X. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
57. Zell, R., K. Klingel, M. Sauter, U. Fortmuller, and R. Kandolf. 1995. Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5′NTR of a chimeric enterovirus RNA: influence of species specific host cell factors on virus growth. Virus Res. 39:871-873.